Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

2.25
BATS BZX Real-Time Price
As of 11:40am ET
 +0.05 / +2.27%
Today’s Change
1.84
Today|||52-Week Range
5.30
-53.51%
Year-to-Date
Athersys (ATHX) Shows Strength: Stock Moves 5.1% Higher
Sep 29 / Zacks.com - Paid Partner Content
Johnson & Johnson's Smart (Yet Surprising) Acquisition
Sep 20 / MotleyFool.com - Paid Partner Content
GW Pharma Attains 52-Week High on Positive Epidiolex Data
Sep 27 / Zacks.com - Paid Partner Content
AveXis (AVXS) Shows Strength: Stock Adds 6.3% in Session
Sep 20 / Zacks.com - Paid Partner Content
Endo Appoints New CEO, Keeps Q3 & '16 View, Stock Jumps
Sep 26 / Zacks.com - Paid Partner Content
Celgene Presents Efficacy & Safety Phase II Ozanimod Data
Sep 20 / Zacks.com - Paid Partner Content
Chiasma (CHMA) Shows Strength: Stock Moves 5.9% Higher
Sep 26 / Zacks.com - Paid Partner Content
Pfizer (PFE) Breast Cancer Drug Ibrance Wins CHMP Backing
Sep 20 / Zacks.com - Paid Partner Content
Biotech Stocks Under $5: 2 to Buy, 1 to Avoid
Sep 24 / MotleyFool.com - Paid Partner Content
Amgen (AMGN) Parsabiv Gets Positive CHMP Opinion in EU
Sep 19 / Zacks.com - Paid Partner Content
Teva Reports Positive Phase III Tardive Dyskinesia Data
Sep 23 / Zacks.com - Paid Partner Content
Curis (CRIS) Shows Strength: Stock Adds 6.9% in Session
Sep 19 / Zacks.com - Paid Partner Content
Amgen (AMGN) Repatha Meets Endpoints in Phase III Study
Sep 21 / Zacks.com - Paid Partner Content
Novavax Tanks, RSV F Vaccine Disappoints in Two Studies
Sep 16 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD ...
Sep 21 / Zacks.com - Paid Partner Content
bluebird bio (BLUE) in Focus: Stock Moves 11.4% Higher
Sep 16 / Zacks.com - Paid Partner Content